• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在被诊断为可能患有阿尔茨海默病的患者中,脑脊液总水平升高,但寡聚体或磷酸化形式的α-突触核蛋白没有升高。

Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease.

机构信息

Neurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation, PO Box 5825, Doha, Qatar.

Department of Anatomy and Neurosciences, Neuroscience Campus Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands.

出版信息

Sci Rep. 2017 Jan 10;7:40263. doi: 10.1038/srep40263.

DOI:10.1038/srep40263
PMID:28071698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5223278/
Abstract

Several studies reported an association between CSF alpha-synuclein (α-syn) and tau in Alzheimer's disease (AD), and demonstrated the significance of α-syn in improving the diagnostic sensitivity/specificity of classical AD CSF biomarkers. In the current study, we measured CSF levels of different α-syn species in a cohort of AD patients (n = 225) who showed a CSF profile typical of AD at baseline as well as in cognitively intact controls (n = 68). CSF total α-syn (t-α-syn) significantly increased in the AD group (p < 0.0001) compared to controls, while oligomeric- and phosphorylated-Ser129-α-syn did not change significantly. ROC analysis showed a sensitivity of 85% and a specificity of 84% (AUC = 0.88) in distinguishing AD from controls. T-α-syn levels correlated positively with tau species in AD group and negatively with baseline MMSE score. Our data support the added value of measurement of CSF α-syn species for further characterization of the CSF AD profile.

摘要

几项研究报告称,脑脊液α-突触核蛋白(α-syn)与阿尔茨海默病(AD)中的 tau 之间存在关联,并证明了 α-syn 在提高经典 AD 脑脊液生物标志物的诊断灵敏度/特异性方面的重要性。在本研究中,我们在一组基线时显示 AD 脑脊液特征的 AD 患者(n=225)和认知正常的对照组(n=68)中测量了不同的 α-syn 物种的脑脊液水平。与对照组相比,AD 组的脑脊液总 α-syn(t-α-syn)显著增加(p<0.0001),而寡聚体和磷酸化 Ser129-α-syn 没有显著变化。ROC 分析显示,区分 AD 与对照组的灵敏度为 85%,特异性为 84%(AUC=0.88)。AD 组的 t-α-syn 水平与 tau 物种呈正相关,与基线 MMSE 评分呈负相关。我们的数据支持测量脑脊液 α-syn 物种以进一步描述 CSF AD 图谱的附加价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80e/5223278/d00347157d98/srep40263-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80e/5223278/16d35c46a6cd/srep40263-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80e/5223278/1f8c9ec2e788/srep40263-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80e/5223278/d00347157d98/srep40263-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80e/5223278/16d35c46a6cd/srep40263-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80e/5223278/1f8c9ec2e788/srep40263-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80e/5223278/d00347157d98/srep40263-f3.jpg

相似文献

1
Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease.在被诊断为可能患有阿尔茨海默病的患者中,脑脊液总水平升高,但寡聚体或磷酸化形式的α-突触核蛋白没有升高。
Sci Rep. 2017 Jan 10;7:40263. doi: 10.1038/srep40263.
2
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.脑脊液脂肪酸结合蛋白 3、α-突触核蛋白与阿尔茨海默病核心生物标志物在路易体疾病和阿尔茨海默病痴呆中的差异作用。
Alzheimers Res Ther. 2017 Jul 28;9(1):52. doi: 10.1186/s13195-017-0276-4.
3
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.寡聚化和磷酸化的α-突触核蛋白作为帕金森病潜在的脑脊液生物标志物
Mol Neurodegener. 2016 Jan 19;11:7. doi: 10.1186/s13024-016-0072-9.
4
CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease.脑脊液 α-突触核蛋白提高了阿尔茨海默病中脑脊液 tau 和 Aβ 的诊断和预后性能。
Acta Neuropathol. 2013 Nov;126(5):683-97. doi: 10.1007/s00401-013-1148-z. Epub 2013 Jun 29.
5
Cerebrospinal fluid α-synuclein contributes to the differential diagnosis of Alzheimer's disease.脑脊液 α- 突触核蛋白有助于阿尔茨海默病的鉴别诊断。
Alzheimers Dement. 2018 Aug;14(8):1052-1062. doi: 10.1016/j.jalz.2018.02.015. Epub 2018 Mar 28.
6
Measurement of CSF α-synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer's disease.脑脊液 α- 突触核蛋白测定有助于提高阿尔茨海默病所致轻度认知障碍的早期鉴别诊断。
J Neurochem. 2019 Jul;150(2):218-230. doi: 10.1111/jnc.14719. Epub 2019 Jul 8.
7
The value of cerebrospinal fluid α-synuclein and the tau/α-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology.脑脊液 α-突触核蛋白和 tau/α-突触核蛋白比值对具有路易体病理的神经退行性疾病的诊断价值。
Eur J Neurol. 2020 Jan;27(1):43-50. doi: 10.1111/ene.14032. Epub 2019 Jul 24.
8
Increased CSF α-synuclein levels in Alzheimer's disease: correlation with tau levels.阿尔茨海默病患者脑脊液中α-突触核蛋白水平升高:与tau 蛋白水平的相关性。
Alzheimers Dement. 2014 Oct;10(5 Suppl):S290-8. doi: 10.1016/j.jalz.2013.10.004. Epub 2014 Jan 15.
9
CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies.阿尔茨海默病和路易体痴呆症中神经元损伤生物标志物视蛋白样蛋白-1 的 CSF 水平。
J Neurochem. 2013 Dec;127(5):681-90. doi: 10.1111/jnc.12331. Epub 2013 Jun 26.
10
Association of cerebrospinal fluid α-synuclein with total and phospho-tau protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers.在根据阿尔茨海默病生物标志物分层的认知正常主观记忆抱怨者中,脑脊液 α-突触核蛋白与总 tau 蛋白和磷酸化 tau 蛋白浓度以及脑淀粉样蛋白负荷的关联。
Alzheimers Dement. 2018 Dec;14(12):1623-1631. doi: 10.1016/j.jalz.2018.06.3053. Epub 2018 Jul 26.

引用本文的文献

1
Early intervention anti-Aβ immunotherapy attenuates microglial activation without inducing exhaustion at residual plaques.早期干预抗Aβ免疫疗法可减轻小胶质细胞激活,而不会在残留斑块处诱导耗竭。
Mol Neurodegener. 2025 Aug 20;20(1):92. doi: 10.1186/s13024-025-00878-1.
2
Phosphorylated α-synuclein in CSF and plasma does not reflect synucleinopathy.脑脊液和血浆中的磷酸化α-突触核蛋白不能反映突触核蛋白病。
NPJ Parkinsons Dis. 2025 Aug 7;11(1):232. doi: 10.1038/s41531-025-01086-w.
3
A manifesto for Alzheimer's disease drug discovery in the era of disease-modifying therapies.

本文引用的文献

1
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.寡聚化和磷酸化的α-突触核蛋白作为帕金森病潜在的脑脊液生物标志物
Mol Neurodegener. 2016 Jan 19;11:7. doi: 10.1186/s13024-016-0072-9.
2
Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.新型α-突触核蛋白病理构象特异性单克隆抗体的产生和鉴定。
Neurobiol Dis. 2015 Jul;79:81-99. doi: 10.1016/j.nbd.2015.04.009. Epub 2015 Apr 30.
3
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.
疾病修饰疗法时代阿尔茨海默病药物研发宣言。
Mol Neurodegener. 2025 Aug 6;20(1):88. doi: 10.1186/s13024-025-00872-7.
4
Distinct CSF α-synuclein aggregation profiles associated with Alzheimer's disease phenotypes and MCI-to-AD conversion.与阿尔茨海默病表型及轻度认知障碍向阿尔茨海默病转化相关的不同脑脊液α-突触核蛋白聚集谱。
J Prev Alzheimers Dis. 2025 Feb;12(2):100040. doi: 10.1016/j.tjpad.2024.100040. Epub 2025 Jan 3.
5
Unlocking early detection of Alzheimer's disease: The emerging role of nanomaterial-based optical sensors.解锁阿尔茨海默病的早期检测:基于纳米材料的光学传感器的新兴作用。
J Food Drug Anal. 2024 Sep 13;32(3):296-324. doi: 10.38212/2224-6614.3520.
6
A cross-sectional study of α-synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function.阿尔茨海默病神经影像学倡议中α-突触核蛋白种子扩增测定的横断面研究:患病率及与阿尔茨海默病生物标志物和认知功能的相关性。
Alzheimers Dement. 2024 Aug;20(8):5114-5131. doi: 10.1002/alz.13858. Epub 2024 May 21.
7
Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases.脑脊液参考蛋白提高了脑部疾病生物标志物的准确性和可解释性。
Nat Commun. 2024 May 1;15(1):3676. doi: 10.1038/s41467-024-47971-5.
8
Biomarkers in Alzheimer's disease.阿尔茨海默病中的生物标志物。
Adv Lab Med. 2020 Nov 23;2(1):27-50. doi: 10.1515/almed-2020-0090. eCollection 2021 Mar.
9
Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease.脑脊液α-突触核蛋白预测前驱期阿尔茨海默病患者发生精神病的效度
Front Neurol. 2023 May 24;14:1124145. doi: 10.3389/fneur.2023.1124145. eCollection 2023.
10
Fluid and Biopsy Based Biomarkers in Parkinson's Disease.基于液体和活检的帕金森病生物标志物。
Neurotherapeutics. 2023 Jul;20(4):932-954. doi: 10.1007/s13311-023-01379-z. Epub 2023 May 3.
与阿尔茨海默病相比,帕金森病伴痴呆和路易体痴呆患者的脑脊液α-突触核蛋白寡聚物水平升高。
Alzheimers Res Ther. 2014 May 7;6(3):25. doi: 10.1186/alzrt255. eCollection 2014.
4
Increased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.克雅氏病患者脑脊液中α-突触核蛋白水平升高。
J Neurol. 2014 Jun;261(6):1203-9. doi: 10.1007/s00415-014-7334-7. Epub 2014 Apr 16.
5
Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry.脑脊液总 tau 和磷酸化 tau 在克雅氏病中的诊断性能:来自瑞典死亡率登记处的结果。
JAMA Neurol. 2014 Apr;71(4):476-83. doi: 10.1001/jamaneurol.2013.6455.
6
Increased CSF α-synuclein levels in Alzheimer's disease: correlation with tau levels.阿尔茨海默病患者脑脊液中α-突触核蛋白水平升高:与tau 蛋白水平的相关性。
Alzheimers Dement. 2014 Oct;10(5 Suppl):S290-8. doi: 10.1016/j.jalz.2013.10.004. Epub 2014 Jan 15.
7
The diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's disease.脑脊液 α-突触核蛋白在路易体痴呆与正常对照及阿尔茨海默病患者鉴别诊断中的诊断价值。
PLoS One. 2013 Nov 25;8(11):e81654. doi: 10.1371/journal.pone.0081654. eCollection 2013.
8
Diagnostic accuracy measures.诊断准确性测量。
Cerebrovasc Dis. 2013;36(4):267-72. doi: 10.1159/000353863. Epub 2013 Oct 16.
9
CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease.脑脊液 α-突触核蛋白提高了阿尔茨海默病中脑脊液 tau 和 Aβ 的诊断和预后性能。
Acta Neuropathol. 2013 Nov;126(5):683-97. doi: 10.1007/s00401-013-1148-z. Epub 2013 Jun 29.
10
α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment.阿尔茨海默病和轻度认知障碍患者脑脊液中的α-突触核蛋白。
J Alzheimers Dis. 2013;36(4):679-88. doi: 10.3233/JAD-130458.